Results 121 to 130 of about 43,533 (201)

Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations. [PDF]

Biomedicines
Dascalu AM, Grigorescu CC, Ergin E, Alexandrescu C, Dumitrescu D, Nedea MI, Cristea BM, Serban D, Tribus LC, Badescu TM.   +9 more
europepmc   +1 more source

Application of continuous care based on IKAP theory in patients with diabetic macular edema. [PDF]

Sci Rep
Wang H, Li H, Wang Y, Liu H, Zhang Y.
europepmc   +1 more source

Patient and Physician Perspectives on the Management of Diabetic Macular Edema. [PDF]

Ophthalmol Ther
Warren B, Donohoe M, Sivaprasad S, Wykoff CC.   +3 more
europepmc   +1 more source

Artificial Intelligence in Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review. [PDF]

Bioengineering (Basel)
Jukić A, Pavan J, Kalauz M, Kopić A, Markušić V, Jukić T.   +5 more
europepmc   +1 more source

Telangiectatic capillaries remodel over time in eyes with persistent diabetic macular edema. [PDF]

Graefes Arch Clin Exp Ophthalmol
Fouad YA, Mohsen R, Dimitry R, Baddar D.
europepmc   +1 more source

Recent advances in the study of Conbercept for diabetic macular edema. [PDF]

Int J Retina Vitreous
Liu Z, Zheng X, Li H.
europepmc   +1 more source

Progress in the treatment of diabetic macular edema with faricimab: a review. [PDF]

Front Med (Lausanne)
Gao M, Liu C, Zeng Y, Wu X, Duan J.
europepmc   +1 more source

"Real world outcomes of intravitreal brolucizumab for persistent diabetic macular edema". [PDF]

Int J Retina Vitreous
Hansraj S, Narula R, Raval VR, Narayanan R, Tyagi M.   +4 more
europepmc   +1 more source

Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]

Drug Des Devel Ther
Tao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc   +1 more source

A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema. [PDF]

Front Pharmacol
Zhai G, Ren X, Xu B, Mi D.
europepmc   +1 more source